(Q33610869)

English

Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Schröder FH

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

83

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

161-170

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Incidental carcinoma of the prostate: an analysis of the predictors of progression

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Prostate cancer facts and fiction.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

X-linked spinomuscular atrophy: a kindred with associated abnormal androgen receptor binding

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00955.X

21 January 2018

Identifiers

10.1046/J.1464-410X.1999.00955.X

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33610869&oldid=1856149564"